Ken Voss (Naperville, Ill.)

DSRCT Diagnosed 10/03 - Passed Away 05/23/2005

 

Completed at least four rounds of the P6 Protocol.

7/7/04 - Ken has been taking Gleevec for two weeks in a phase 2 clinical trial.

 

 

 

 

 

 

www.dsrct.com     desmoplastic small round cell tumor